Our featured content

Healthcare – Nov 10, 2022

Xeltis starts pivotal clinical trial with first ever restorative synthetic hemodialysis access graft

Xeltis announced the initiation of a pivotal trial for the first-ever restorative synthetic hemodialysis access grafts, aXess. The first two patients have been successfully implanted, as part of the AXESS European pivotal trial at AZ Sint-Jan Brugge-Oostende AV in Bruges, Belgium by vascular surgeon Dr. Jan De Letter and discharged from hospital.

Healthcare – Nov 01, 2022

VI Partners welcomes Gaetano Zanon as Venture Partner, Technology

VI Partners, the longest-established VC team in Switzerland, welcomes Gaetano Zanon as new Venture Partner. Gaetano joins the Technology Investment team.

Healthcare – Oct 04, 2022

Sibylla Biotech Raises €23 Million Series A round

Sibylla Biotech today announced the successful close of its €23 million Series A financing round to fund the further development of its Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT) approach, which provides access to a new class of pharmacological targets that transiently appear during the process of protein folding, and to advance its proprietary pipeline programsthrough preclinical evaluation.

Healthcare – Sep 29, 2022

Honing the opportunity and inspiration of venture capital. An interview with Simon Meier

He’s spent one and a half decades investing in Digital Health, Diagnostic and Biotech companies in Europe and the US. Now, Simon Meier wants to help founders move away from caution and focus on the potential their ambition and grit can deliver.

Technology – Sep 01, 2022

10 million for Swiss e-signature scale-up Skribble

Skribble, the leading Swiss e-signature service, closes its third round of funding. The scale-up has secured 10 million Swiss francs as part of its Series A. The round is co-led by venture capital firms VI Partners from Switzerland and Acton from Germany. With the capital raised, Skribble aims to strengthen its position as a pioneer in existing markets and drive expansion in Europe.

Technology – Jul 13, 2022

Morgen raises CHF 1 million in pre-seed funding to revolutionize time management

Backed by VI Partners, Morgen wants to be the only productivity tool worthy of your time. Morgen, now in its second year, has raised $1 million in pre-seed funding. Swiss VI Partners led the round, with participation from New Forge.

Technology – Apr 27, 2022

Low-code provider Ninox continues to grow and gain new investors

Berlin-based B2B SaaS start-up expands its market position among SMEs and successfully closes financing round for another € 8 million.

Technology – Apr 26, 2022

Picterra raises $6.5M to accelerate its mission of democratizing geospatial mapping

Picterra, the leading provider of geospatial machine learning software, today announced the closing of a $6.5M investment. Led by venture capital firm VI Partners, with participation from ACE & Company, the investment will enable Picterra to pursue its mission of democratizing access to Earth observation imagery and geospatial ML.

Latest News

Our credo

Entre­preneurs improve the world. We proudly support them.

Our heritage

Who we are and how we started 


VI Partners' founding team came together in 2000 to advise Venture Incubator, an investment vehicle initiated by ETHZ and funded by ten blue-chip Swiss companies. Today, we advise funds investing across Europe in tech and healthcare.